Cargando…
Angioedema Secondary to IV Tissue Plasminogen Activator Administration for Treatment of Acute Ischemic Stroke
BACKGROUND: IV tissue plasminogen activator (tPA) is the treatment of choice for ischemic strokes that present within the treatment window. In the majority of patients, this offers an effective and often life-prolonging treatment in the acute setting. In a rare set of patients treated with IV tPA, s...
Autores principales: | Chaucer, Benjamin, Whelan, Dustin, Veys, Christopher, Upadhyaya, Manas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925031/ https://www.ncbi.nlm.nih.gov/pubmed/29850270 http://dx.doi.org/10.1155/2018/3257215 |
Ejemplares similares
-
Association of Geographical Factors With Administration of Tissue Plasminogen Activator for Acute Ischemic Stroke
por: Kunisawa, Susumu, et al.
Publicado: (2013) -
Hemi Orolingual Angioedema after tPA Administration for Acute Ischemic Stroke
por: Madden, Bryan, et al.
Publicado: (2015) -
Angioedema: A Life-threatening Complication of Tissue Plasminogen Activator
por: Khalid, Muhammad, et al.
Publicado: (2018) -
Angioedema after thrombolysis with tissue plasminogen activator: an airway emergency
por: Rathbun, Kimberly M
Publicado: (2019) -
Perception Versus Actual Performance in Timely Tissue Plasminogen Activation Administration in the Management of Acute Ischemic Stroke
por: Lin, Cheryl B, et al.
Publicado: (2015)